Fritextsökning
Innehållstyper
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Investeraren: "Våra bolag måste ha en plan för USA"
Karolinska Development vill att deras bolag ska ha en chans på den mer lönsamma marknaden i USA.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Vad händer inom bioprocess närmaste fem åren?
New horizons in bioprocessing and biologics är ett tekniskt möte för de insatta, men vi passar på att fråga. Vad händer inom levande läkemedel närmaste fem åren?
-
Ny teknik kan upptäcka alzheimer tidigare
Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Ny design på klinstudie
I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Samuel Lagercrantz: Framgången kommer efter många misslyckanden
De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Inga svenska företag i topp 50
Varje år sammanställer Boston Consulting Group en lista över världens 50 mest innovativa företag. Inga svenska företag finns representerade på årets lista som t...
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.